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Abstract: Chronic intermittent hypoxia (CIH) induces lipid peroxidation and leads to 
cardiovascular dysfunction, in which impaired activities of the adrenal medulla are involved. 
This may be caused by CIH-induced injury in the adrenal medulla, for which the mechanism 
is currently undefined. We tested the hypothesis that melatonin ameliorates the CIH-induced 
lipid peroxidation, local inflammation and cellular injury in rat adrenal medulla. Adult 
Sprague–Dawley rats were exposed to air (normoxic control) or hypoxia mimicking a severe 
recurrent sleep apnoeic condition for 14 days. The injection of melatonin (10 mg/kg) or 
vehicle was given before the daily hypoxic treatment. We found that levels of 
malondialdehyde and nitrotyrosine were significantly increased in the vehicle-treated 
hypoxic group, when compared with the normoxic control or hypoxic group treated with 
melatonin. Also, the protein levels of antioxidant enzymes (superoxide dismutase (SOD)-1 
and SOD-2) were significantly lowered in the hypoxic group treated with vehicle but not in 
the melatonin group. In addition, the level of macrophage infiltration and the expression of 
inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6) and 
mediators (inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2)) were 
elevated in the vehicle-treated hypoxic group, but were significantly ameliorated by the 
melatonin treatment. Moreover, the amount of apoptotic cells in the hypoxic groups was 
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significantly less in the melatonin-treated group. In conclusion, CIH-induced lipid 
peroxidation causes local inflammation and cellular injury in the adrenal medulla. The 
antioxidant and anti-inflammatory actions of melatonin are indicative of a protective agent 
against adrenal damage in patients with severe obstructive sleep apnea syndrome. 
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1. Introduction 
Patients with sleep-disordered breathing suffer from recurrent episodes of apnea/hypopnea caused  
by obstruction of the upper airway and/or lowered central ventilatory activities. It is known that  
patients with obstructive sleep apnea (OSA) syndrome have increased risks of developing hypertension, 
cardiovascular diseases and neuro-cognitive deficits [1–3]. Studies have also shown that recurrent 
episodes of apnea/hypopnea cause chronic intermittent hypoxia (CIH), which induces lipid peroxidation 
and subsequently causes the pathophysiological change in the OSA patient [4–6]. Indeed, we have shown 
that CIH-induced lipid peroxidation plays a significant pathogenic role in the hippocampal injury in a 
rat model with chronic exposure to intermittent hypoxia mimicking a severe OSA condition, which 
underpins the involvement of overproduction of reactive oxygen species (ROS) and free radicals in 
apoptotic cell death and neuronal dysfunction [7,8]. In addition, it has been shown that that cellular 
injuries caused by lipid peroxidation lead to inflammation, which induces the inflammatory response 
that could be an important contributing factor in promoting cardiovascular morbidity in OSA patients [9,10]. 
In fact, lipid peroxidation and ROS are potent inducers of inflammatory pathways that promote the 
expression of adhesion molecules and pro-inflammatory cytokines [11]. A growing amount of evidence 
supports pathophysiological roles of CIH-induced lipid peroxidation and inflammation in cardiovascular 
morbidities in OSA patients [12–14]. 
The adrenal medulla is an important effector for the autonomic regulation of the cardiovascular 
response to hypoxia [15,16]. The production and release of catecholamines from the adrenomedullary 
chromaffin cells are not only crucial to the cardiovascular response to hypoxia [17,18] but also to the 
proper respiratory and metabolic responses to asphyxia [19]. In OSA patients, elevated levels of the 
sympathetic activity and circulating catecholamines are indicative of pathophysiological changes in the 
adrenal medulla. However, there is paucity information on the lipid peroxidation and cellular injuries in 
the adrenal medulla, if any, and its pathogenic mechanism under CIH conditions. 
Melatonin, which is secreted from the pineal gland, possesses antioxidant and anti-inflammatory 
properties at both physiological and pharmacological concentrations [20–24]. Pharmacological doses of 
exogenously administered melatonin are known to be protective against free radicals [25] shown in  
a number of pathological conditions such as hypoxia-induced hepatic injury and the ischemic-reperfusion 
injuries in the skeletal muscle, heart, and brain [26–29]. In this study, we aimed to examine the hypothesis 
that melatonin is protective against the lipid peroxidation, local inflammation and cellular injury induced 
by CIH in the adrenal medulla in rats. 
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2. Results 
The malondialdehyde (MDA) level in the adrenal medulla was significantly increased in the  
hypoxic group treated with vehicle, when compared with that of the normoxic control. The MDA  
level was remarkably decreased to the normoxic level by the melatonin treatment (Figure 1A). The  
protein expressions of the antioxidant enzymes, superoxide dismutase (SOD)-1 and SOD-2 in the adrenal 
medulla were examined by Western blot study. The protein levels of SOD1 and SOD2 were significantly 
lowered in the vehicle-treated hypoxic group (Figure 1B). 
Figure 1. Levels of malondiadehyde (MDA) and the protein expression of antioxidant 
enzymes in adrenal medulla of hypoxic rats and controls. (A) The level of MDA was 
significantly increased in the IH group when compared with the normoxic control and 
hypoxic group co-treated with melatonin; and (B) antioxidant enzymes protein expression 
was significantly lower in the IH group than those of the normoxic control and MIH groups  
(* p < 0.05, versus normoxic control; # p < 0.05, versus IH group. n = 6 per group). Nx, 
normoxic control; IH, intermittent hypoxia; MIH, melatonin-treated intermittent hypoxia. 
(A) 
(B) 
Immunohistochemical studies revealed that the immunoreactivity of nitrotyrosine (NTR)  
was present in the adrenal medulla. Image analysis measuring the % adrenal medulla area with  
positive-immunostaining of NTR showed a significant increase in the NTR level in the hypoxic groups 
when compared with the normoxic control. The NTR level in melatonin-treated hypoxic group was 
significantly lower than that of the vehicle-treated group (Figure 2). These results suggest an increased 
level of reactive nitrogen species (RNS) caused by CIH-induced oxidative stress in the adrenal medulla 
under CIH condition, which could be mitigated by melatonin treatment. 
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Figure 2. Immunostaining of nitrotyrosine (NTR) in the adrenal medulla of hypoxic rats and 
controls. (A) The positive-immunoreactivity of NTR was significantly increased in the 
hypoxic groups (IH and MIH group) than the Nx, but it was attenuated by the melatonin 
treatment (MIH group); and (B) Data are presented in % area with positive staining of  
NTR immunoreactivity. (* p < 0.05, versus normoxic control; # p < 0.05, versus IH group.  
n = 6 per group). Nx, normoxic control; IH, intermittent hypoxia; MIH, melatonin-treated 
intermittent hypoxia. 
 
(A) 
(B) 
To examine the infiltration of macrophages in the adrenal medulla, double-staining of cellular 
markers for macrophages, anti-CD68 antibody (ED1), and for adrenochromaffin cells, and tyrosine 
hydroxylase (TH), was performed. Results showed that the sectional area with ED1-positive staining 
(%) was significantly increased in the hypoxic groups but the increase was much less in the  
melatonin-treated hypoxic group (Figure 3), indicating an increase in the infiltration of macrophages in 
the adrenal medulla under CIH condition, which could be attenuated by the melatonin treatment. 
The protein expressions of inflammatory cytokines, namely interleukin (IL)-1β, IL-6 and tumor 
necrosis factor (TNF)-α, and mediators including cyclooxygenase-2 (COX-2) and inducible nitric oxide 
synthase (iNOS), in the adrenal medulla were examined by Western blotting study and ELISA assay. 
The expression levels of the inflammatory cytokines (IL-1β, IL-6 and TNF-α) and mediators (iNOS and 
COX-2) were significantly higher in the vehicle-treated hypoxic group than those in the normoxic and 
melatonin-treated group (Figure 4). 
The amount of apoptotic cells in the adrenal medulla was assessed by TUNEL assay. The sectional 
area with TUNEL-positive staining (%) was significantly increased in the hypoxic groups but the 
increase was much less in the melatonin-treated hypoxic group (Figure 5), suggesting that melatonin is 
protective against CIH-induced cell death in the adrenal medulla.  
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Figure 3. The localization and expression of ED1-containing macrophages and tyrosine 
hydroxylase (TH) in the adrenal medulla of hypoxic rats and controls. (A) The ED1 (red) 
and TH (green) expression was significantly more in the hypoxic groups (IH and MIH group) 
than the Nx, but it was attenuated by the melatonin treatment (MIH group); and (B) Data are 
presented in % area with positive staining of ED1 immunoreactivity. (* p < 0.05, versus 
normoxic control; # p < 0.05, versus IH group. n = 6 per group). Nx, normoxic control; IH, 
intermittent hypoxia; MIH, melatonin-treated intermittent hypoxia. 
 
(A) 
(B) 
Figure 4. Levels of the protein expression of pro-inflammatory cytokines and mediators in 
adrenal medulla. (A) Protein expression of pro-inflammatory mediators were significantly 
higher in the IH group than those of the normoxic control and MIH groups; and (B) Protein 
expression of pro-inflammatory cytokines characterized by ELISA. (* p < 0.05, versus 
normoxic control; # p < 0.05, versus IH group. n = 6 per group). Nx, normoxic control; IH, 
intermittent hypoxia; MIH, melatonin-treated intermittent hypoxia. 
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Figure 4. Cont. 
 
(A) 
 
(B) 
Figure 5. TUNEL-staining of apoptotic cells in the adrenal medulla was increased in  
the hypoxic groups (IH and MIH group) but the increase was less in the MIH group.  
(A) TUNEL-staining in sections of the adrenal medulla in Nx, IH and MIH groups;  
and (B) Summary of % TUNEL-staining in the adrenal medulla. Calibration bar is 20 μm. 
(* p < 0.05, versus normoxic control; # p < 0.05, versus IH group. n = 6 per group).  
NC, negtive control; PC, positive control; Nx, normoxic control; IH, intermittent hypoxia;  
MIH, melatonin-treated intermittent hypoxia. 
(A) 
(B) 
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3. Discussion 
In this study, we demonstrated that the CIH exposure mimicking a severe OSA condition in rats 
induces lipid peroxidation, local inflammation and apoptotic cell death in the adrenal medulla with 
decreased expressions of antioxidant enzymes (Figure 6). We also showed that the administration of 
melatonin significantly ameliorated the CIH-induced lipid peroxidation and local inflammation. Lipid 
peroxidation is one of the major processes mediating the breakdown of membrane lipids leading to 
cellular injuries caused by free radicals during oxidative insults [30,31]. The MDA level is elevated 
when the membrane lipoproteins and polyunsaturated fatty acids are attacked by free radicals, which 
estimates the level of lipid peroxidation [32–34]. Although it is not a direct measurement of oxidative 
stress, we found an increased MDA level in the adrenal medulla of hypoxic rats, suggesting elevated 
levels of lipid peroxidation, which could be mediated by CIH-induced oxidative stress. This is consistent 
with our previous studies reporting antioxidant melatonin attenuated the elevated MDA levels and 
cellular injuries induced by CIH-induced lipid peroxidation [7,8]. Also, our results showed the increased 
level of NTR-immunoreactivity in the adrenal medulla of CIH rats. Since the NTR is an indicator of 
cellular injuries and inflammation mediated by RNS and ROS in oxidative stress [35,36], the increased 
NTR level suggests that the CIH-induced oxidative stress could lead to the injury of adrenochromaffin 
cells in the adrenal medulla. This is supported by the finding that apoptotic cells were significantly more 
in the adrenal medulla in the hypoxic groups. Furthermore, antioxidant enzymes are important cellular 
defenders against oxidative stress [37]. The finding of a significant decrease in the protein expression of 
antioxidant enzymes in the adrenal medulla of hypoxic rats indicates an involvement of lowered 
antioxidant capacity in the CIH-induced lipid peroxidation, leading to the local inflammation and cell 
death in the adrenal medulla. 
Figure 6. Melatonin ameliorates the cellular injuries in the adrenal medulla mediated by 
lipid peroxidation and inflammation induced by intermittent hypoxia. 
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Inflammation plays an important role in the pathogenesis of tissue injury in response to lipid 
peroxidation in the adrenal medulla. We found an increase in the infiltration of macrophage in the adrenal 
medulla of CIH rats, which was attenuated by melatonin treatment. This suggests a local inflammation in the 
adrenal gland with activated macrophages, which are known to be capable of producing pro-inflammatory 
cytokines, free radicals and myeloperoxidase in inflamed tissues. In addition, macrophages could play an 
important role in the removal of necrotic debris and apoptotic cells. Also, activated macrophages are 
responsible for the release of growth factors for angiogenesis and turnover of extra-cellular matrix, which 
are vital requisites for the tissue healing and regeneration. Furthermore, the induction of the expressions of 
inflammatory mediators, including COX-2 and iNOS, and cytokines IL-1β, IL-6, and TNF-α, play important 
roles in the tissue and cellular injuries under lipid peroxidation [38–41]. In fact, the protein expressions of 
these inflammatory mediators were consistently increased in the vehicle-treated hypoxic group, suggesting 
that there is a close link between lipid peroxidation and inflammation during hypoxia. These could cause 
apoptotic cell death mediated by a mitochondria-mediated intrinsic apoptotic pathway, characterized by 
the activation of caspases induced by lipid peroxidation under CIH conditions [42]. Thus, oxidative 
insults mediated by locally produced ROS, and mitochondrial release of cytochrome c could activate 
caspase-3, leading to apoptosis in the adrenal medulla [43]. 
Composed mainly of hormone-producing chromaffin cells, the adrenal medulla is the principal site 
of the conversion of the amino acid tyrosine into the catecholamines epinephrine, norepinephrine, and 
dopamine. Studies in both humans and experimental models have shown that CIH leads to hypertension 
as well as increased circulating catecholamines [44–46]. Recently, studies have shown that CIH 
increases the release of catecholamines from adrenal chromaffin cells via ROS-mediated activation of 
protein kinase C (PKC) and enhanced neuropeptide Y synthesis by ROS, thus elevating the circulating 
catecholamines and arterial pressures [15,18,47]. Also, Peng et al. [48] reported that the muscarinic 
acetylcholine receptor-mediated calcium influx in the adrenal medulla plays a role in the oxidative stress 
and HIF-α isoform imbalance mediated by CIH-induced sympathetic activation, resulting in the 
activation of mammalian target of rapamycin pathway and calpain proteases. In this context, the 
increased level of lipid peroxidation and inflammation may also be involved in the pathological cascade 
leading to elevated release of catecholamines in the adrenal medulla under CIH conditions. 
Melatonin is a potent ROS scavenger which exerts antioxidant effects against CIH-induced lipid 
peroxidation. Indeed, our results showed that administration of melatonin significantly decreased the 
amount of MDA and NTR and also markedly reduced the expressions of these inflammatory cytokines 
and mediators in the adrenal medulla of the hypoxic rat. This is in consistent with our previous studies 
showing the protective effect of melatonin against CIH-induced neuronal and cardiac injuries [7,8]. The 
known neuroprotective effect of melatonin is, in part, attributed to its antioxidant property against the 
lipid peroxidation in the central nervous system during oxidative insults [49–51]. In fact, melatonin, which 
directly scavenges ROS, also reduces lipid peroxidation indirectly through mediating an up-regulation of 
the expression of antioxidant enzymes [52,53]. In addition, recent evidence showed that melatonin 
modulates neuro-inflammation by inhibiting the NF-κB pathway and downstream mediators of 
inflammation. Also melatonin protects against lipid peroxidation and inflammation by upregulating the 
nuclear erythroid 2-related factor 2 (Nrf2) pathway [54]. Besides, melatonin can inhibit the apoptosis by 
acting on the abundance of the two main members of the Bcl-2 family [55–60]. Thus, the potent 
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antioxidant and anti-inflammatory properties of melatonin are central to its protective effects against 
cellular injuries in the adrenal medulla. 
In conclusion, our results support the hypothesis that CIH-induced lipid peroxidation is involved in 
local inflammation and apoptosis in the rat adrenal medulla. Administration of melatonin, as an antioxidant 
agent, could prevent the CIH-induced tissue injury and local inflammation in the adrenal medulla. 
4. Material and Methods 
4.1. Treatment of Chronic Intermittent Hypoxia in Rats 
Healthy Sprague–Dawley rats age 28 days (~150 g weight) were randomly divided into two groups, 
namely normoxic control (Nx), and CIH (n = 6). While the Nx rats were maintained in room air, CIH 
rats were kept in acrylic chambers for normobaric hypoxia in the same room and had free access to  
water and regular chow. The oxygen fraction inside the chamber was cyclic between 5% ± 0.5% and 
21% ± 0.5% per min, 8 h per day diurnally. The desired oxygen content was established by a mixture of 
room air and nitrogen that was regulated and monitored by an oxygen analyzer (Vacumetrics Inc., 
Ventura, CA, USA). The rats were exposed to CIH for 14 days and then were immediately sacrificed 
after being removed from the chambers. 
4.2. Drug Preparation 
Melatonin (Sigma, St. Louis, MO, USA) solution was prepared freshly before injection by dissolving 
the indoleamine in absolute ethanol and further dilution with normal saline; the final concentration of 
ethanol was 2%. Melatonin in 10 mg/kg body weight or vehicle (2% ethanol in normal saline) was 
administered intraperitoneally each day 30 min before hypoxic exposure.  
4.3. Measurement of Malondialdehyde (MDA) Formation 
The MDA level was determined using a BIOXYTECH LPO-586™® kit (OxisResearch, Scottsdale, 
OR, USA). The reaction product was measured spectrophotometrically at 586 nm. Standard curves were 
constructed with 1,1,3,3-tetraethoxypropane as a standard. The MDA concentration (μM) in adrenal 
medulla was normalized to wet tissue weight (mg) and expressed as μmol/mg. 
4.4. Immunohistochemistry 
Following deep anesthesia with halothane, the rat was decapitated and the adrenal gland was excised 
rapidly. The adrenal medulla was carefully dissected out and was fixed in neutral buffered formalin for 
72 h. Tissues were processed routinely for histology and embedded in paraffin blocks. Serial sections of 
5 µm thickness were cut and mounted on silanized slides (Dako Denmark A/S, Denmark). Sections were 
kept in the oven overnight at 56 °C. Consequently, sections were dewaxed with xylene and rehydrated 
with a series of decreasing grades of ethanol solution. Sections were immunostained with antiserum to 
nitrotyrosine (NTR) (goat polyclonal antibody, 1:500 dilution, Santa Cruz Biotechnology, Santa Cruz, 
CA, USA), using LSAB kit (K0690, Dako Denmark A/S, Dako, Denmark) and were deparaffinized and 
rehydrated. Sections were immersed in antigen retrieval solution (0.1 M citric acid buffer, pH 6.0) for 
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10 min at 98 °C. To block endogenous peroxidase activity, the sections were immersed in 3% hydrogen 
peroxide for 5 min at room temperature. Sections were pre-incubated with 20% normal serum for 2 h to 
reduce non-specific binding for the anti-serum. Then sections were incubated with the corresponding 
primary antibodies in 0.05 M Tris–HCl buffer, respectively, containing 2% bovine serum albumin 
overnight at 4 °C. Followed by three times washing in PBS, the sections were incubated with biotinylated 
link agent and streptavidin peroxidase for 30 min at room temperature. Finally, sections were washed 
and the peroxidase was visualized by immersing in 0.05% diaminobenidine (DAB, Dako Denmark A/S, 
Dako, Denmark) containing 0.03% hydrogen peroxide in Tris–HCl buffer (pH 7.5) for 3–5 min. Mild 
counterstaining with hematoxylin was then performed. Positive staining was indicated by a brown color. 
Control sections were incubated with either normal mouse or rabbit IgG and stained uniformly negative. 
4.5. Immunofluorescence Double Staining 
Paraffin sections were processed for indirect immunofluorescent double staining as reported previously. 
Briefly, sections were incubated overnight at 4 °C with rabbit anti-rat ED1 serum, diluted to 1:80, followed 
with anti-tyrosine hydroxylase serum (Chemicon International Inc., Temecula, CA, USA), diluted to 1:100 
overnight at 4 °C. After rinses in PBS, the primary antibodies were detected using anti-rabbit serum labeled 
with rhodamine (1:100, Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) for ED1 and 
anti-sheep serum labeled with FITC (1:100, Jackson ImmunoResearch Laboratories Inc.) for TH at room 
temperature for 2 h. Positive immunoreactivity for ED1 (red) and for TH (green) was examined with a 
fluorescent microscope with a DC 200 digital camera (Leica Microsystems Ltd., Heerbrugg, Switzerland). 
For the control, primary antibodies were substituted with buffer and sections were incubated with rabbit 
non-immune serum. 
4.6. Western Blotting 
The membrane and cytosolic protein extractions were performed by using the ProteoExtract  
native membrane protein extraction kit (Merck KGaA, Darmstadt, Germany) and protocols of 
immunoblotting of proteins was described previously [8,61–63]. In brief, the SD rats were deeply 
anesthetized and decapitated. Adrenal glands were quickly removed and chilled in the ice-old PBS 
solution. The adrenal medulla were dissected and were immediately frozen in liquid nitrogen and stored 
at −70 °C. Samples were homogenized in the ice-cold extraction buffer I containing 10 μL protease 
inhibitor cocktail (Merck) and centrifuged at 16,000× g for 15 min at 4 °C. Supernatant enriched in 
cytosolic proteins was transferred to the sample tube. Pellet was added with ice-cold extraction buffer II 
containing 10 μL protease inhibitor cocktail. The pellet was resuspended gently using a pipette and 
incubated for 30 min at 4 °C. The samples were centrifuged at 16,000× g for 15 min at 4 °C. Supernatant 
containing membrane fraction and membrane protein was transferred completely into sample tubes. The 
amount of protein was determined using protein assay (Bio-Rad Laboratories, Hercules, CA, USA). 
Proteins were mixed with Laemmi buffer containing lysis buffer, 10% 2-mercaptoethanol, and 2 mg/mL 
bromophenol blue. Samples were incubated at 70 °C for 30 min and 60 μL of each sample was loaded 
in each well of a 7.5% SDS-polyacrylamide mini-gel. Membranes were then transferred to 
polyvinylidene difluoride membranes using a transblotting apparatus (Bio-Rad Laboratories) for 30 min. 
Then membranes were incubated at room temperature for 2 h in TBS buffer with 5% skimmed milk, 
Int. J. Mol. Sci. 2014, 15 18447 
 
 
followed by incubating with primary monoclonal antibody COX-2 (rabbit polyclonal antibody, 1:500 
dilution, Cat # sc-7951, Santa Cruz), IL-6 (goat polyclonal antibody, 1:1000 dilution, Cat # sc-1265, Santa 
Cruz), iNOS (mouse monoclonal antibody, 1:500 dilution, Cat # sc-7271, Santa Cruz), SOD1 (rabbit 
polyclonal antibody, 1:1000 dilution, Cat # sc-11407, Santa Cruz) and SOD2 (rabbit polyclonal antibody, 
1:1000 dilution, Cat # sc-30080, Santa Cruz) in TBS buffer with 5% skimmed milk for overnight at 4 °C. 
After incubation, membranes were washed and incubated with second antibody, anti-rabbit IgG 
conjugated to HRP for COX-2 and SOD1 (1:10,000), anti-goat IgG conjugated to HRP for SOD2 and 
IL-6 (1:10,000), anti-mouse IgG conjugated to HRP for iNOS (1:10,000) in TBS solution with 5% 
skimmed milk for 1 h. Then blots were developed using chemiluminescence reagent. Films were exposed 
and analyzed by using Image J software (National Institutes of Health, Bethesda, MD, USA). Results were 
expressed in relative optical density. 
4.7. Enzyme-Linked Immunosorbent Assay (ELISA) Measurement 
ELISA measurements of TNF-α and IL-1β were performed by using corresponding ELISA 
development kits from PeproTech (PeproTech Inc., Rocky Hill, NJ, USA) according to user instructions. 
4.8. Apoptosis Measurement 
To demonstrate the apoptotic cell death in the adrenal medulla, the terminal deoxynucleotidyl 
transferase-mediated dUTP-nick end labeling (TUNEL) assay, which detects 3' hydroxyl ends in 
fragmented DNA as an early event in apoptotic cascade, was used. After dewaxation and rehydration  
of the paraffin-embedded tissue sections, stainings were performed according to the manufacturer’s 
instructions regarding the TUNEL assay by using the in situ cell death detection kit (Roche Applied 
Science, Mannheim, Germany). DNase I recombinant in the sections was used as the positive control. 
Label solution without terminal transferase was used in place of TUNEL reaction mixture for negative 
control. The positive immunostainings of TUNEL were examined by light microscope (Zeiss Axiolab, 
Carl Zeiss Inc., Oberkochen, Germany). 
4.9. Statistical Analysis 
Results are presented as means ± S.E.M. and statistical analyses between groups are one-way ANOVA 
with post-hoc tests for multiple comparisons. Statistical significance was considered at p < 0.05. 
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